Clinical

Articles

Although stone disease in pediatric patients is on the rise and minimally invasive techniques to deal with it are increasing, there is a lack of evidence-based standards to care for these patients.

Stone disease in kids rising, creating challenges

Urologists' reports of stones in pediatric patients varies by region.

Are you seeing more renal stones in your younger patients?

Hypocitraturia is the leading metabolic risk factor in children with stone disease, and the majority of a study's cohort had an identifiable metabolic cause for their urolithiasis.

Hypocitraturia leading metabolic factor in kids with stone disease

Undiagnosed constipation, rather than problems with the bladder, may be to blame for nocturnal enuresis in some children, say researchers from Wake Forest Baptist Medical Center, Winston-Salem, NC.

Some bedwetting in kids may be caused by constipation

Urologists think it's up to parents to decide whether circumcision should be performed on their child.

What do you think of recent efforts to ban circumcision?

A population-based study evaluating 25-year trends in renal stone findings among children reported a 4% per year increase in incidence driven by consistently escalating renal stone rates in the 12- to 17-year age group.

Renal stone incidence increasing among adolescents

Radiation and surgical techniques for treating kidney stones may not be appropriate in a pediatric population.

Kidney stone rate in kids brings new challenges

Tubularized urethras can be engineered from autologous cells and used successfully in the reconstruction of complex posterior urethral defects in children to maintain function long-term.

Tissue-engineered urethras maintain function long-term

Continuing progress in the area of tissue engineering holds the greatest potential impact, not just in pediatric urology or even the entire specialty, but for medicine and society as a whole.

Advances in tissue engineering hold great promise for pediatric urology

The first-ever nationwide survey of antibiotic use in children with urinary tract infections found that the use of third-generation cephalosporins more than doubled between 1998 and 2007.

Pediatrics